ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease

<div>Up-and-down sequential allocation analysis of intranasal DEX was performed in all pediatric patients receiving sedation for TTE in both groups. The dose increment/decrement was 0.2 <i>μ</i>g/kg. The calculated ED50 was 2.486 <i>μ</i>g/kg (2.530 <i>μ</i>g/kg) in group A and 2.485 <i>μ</i>g/kg (2.500 <i>μ</i>g/kg) in group B.</div>

BioMed Research International

fig2

Figure 2

Figure 2: ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease 

Figure 2 | ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease 